Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

SHA:600566 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3,862	5,439	6,669	7,738	4,819	3,819
Trading Asset Securities	7,898	6,266	5,161	3,178	3,045	1,675
Cash & Short-Term Investments	11,760	11,705	11,830	10,916	7,863	5,494
Cash Growth	7.56%	-1.06%	8.37%	38.82%	43.13%	30.28%
Accounts Receivable	1,339	2,109	2,257	2,782	2,850	2,183
Other Receivables	21.36	27.81	12.5	14.99	17.2	11.98
Receivables	1,360	2,137	2,270	2,797	2,867	2,195
Inventory	410.91	309.67	569.09	490.08	391.48	375.59
Other Current Assets	57.49	28.68	32.6	32.5	54.23	58.34
Total Current Assets	13,589	14,180	14,702	14,235	11,177	8,123
Property, Plant & Equipment	2,237	2,445	2,706	2,922	2,856	3,034
Long-Term Investments	497.51	473.11	464.71	393.97	332.34	328.44
Goodwill	167.3	167.3	167.3	167.3	167.3	167.3
Other Intangible Assets	435.09	337.89	308.56	305.01	320.62	280.04
Long-Term Deferred Tax Assets	31.9	49.44	41.83	45.45	62.16	57.32
Long-Term Deferred Charges	9.86	10.01	2.38	11.91	3.87	13.19
Other Long-Term Assets	134.51	37.79	66.44	62.16	62.14	127.96
Total Assets	17,102	17,700	18,459	18,144	14,981	12,131

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1,005	1,314	1,730	2,141	1,505	945.77
Accrued Expenses	83.49	237.25	254.87	246.62	350.39	242.7
Short-Term Debt	1,086	717.55	836.39	1,088	400	-
Current Portion of Long-Term Debt	159.86	68.01	-	-	-	627.55
Current Portion of Leases	-	0.67	1.07	1.06	0.44	1.55
Current Income Taxes Payable	139.48	164.5	99.77	182.62	106.09	43.71
Current Unearned Revenue	26.96	13.62	17.92	17.25	49.14	19.34
Other Current Liabilities	284.37	360.29	598.01	915.86	1,016	919.98
Total Current Liabilities	2,786	2,876	3,538	4,592	3,427	2,801
Long-Term Leases	19.4	0.81	1.04	1.43	0.2	1.02
Long-Term Unearned Revenue	51.49	58.14	65.45	71.43	78.19	84.63
Long-Term Deferred Tax Liabilities	136.79	132.6	127.84	109.28	122.05	112.38
Other Long-Term Liabilities	0.22	0.29	0.53	0.82	1.06	1.35
Total Liabilities	2,993	3,068	3,733	4,775	3,629	3,000

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	452.71	452.51	452.69	452.74	452.74	436.27
Additional Paid-In Capital	4,029	4,016	4,012	3,999	3,984	3,148
Retained Earnings	9,666	10,204	10,345	9,010	6,998	5,431
Treasury Stock	-50.75	-66.74	-108.57	-111.97	-97.18	-
Comprehensive Income & Other	-	-	-	-	-	100.81
Total Common Equity	14,097	14,606	14,702	13,349	11,337	9,117
Minority Interest	11.58	27.11	24.57	19.42	15.14	14.17
Shareholders' Equity	14,108	14,633	14,726	13,369	11,352	9,131
Total Liabilities & Equity	17,102	17,700	18,459	18,144	14,981	12,131

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1,265	787.03	838.5	1,090	400.65	630.12
Net Cash (Debt)	10,495	10,918	10,992	9,826	7,463	4,864
Net Cash Growth	2.81%	-0.68%	11.86%	31.67%	53.43%	34.56%
Net Cash Per Share	11.38	11.85	11.98	10.72	8.22	5.40
Filing Date Shares Outstanding	922.66	921.34	911.19	921.81	921.82	888.27
Total Common Shares Outstanding	922.66	921.34	911.19	921.81	921.82	888.27
Working Capital	10,803	11,304	11,164	9,644	7,749	5,322
Book Value Per Share	15.28	15.85	16.13	14.48	12.30	10.26
Tangible Book Value	13,494	14,100	14,226	12,877	10,849	8,670
Tangible Book Value Per Share	14.63	15.30	15.61	13.97	11.77	9.76
Buildings	-	3,008	2,953	2,911	2,455	2,473
Machinery	-	1,768	1,728	1,685	1,644	1,566
Construction In Progress	-	56.32	156.63	186.98	352.15	322.17

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error